Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 30 Sep 2016

PHARMANIAGA BERHAD

Financial Year End 31 Dec 2016
Quarter 3 Qtr
Quarterly report for the financial period ended 30 Sep 2016
The figures have not been audited

Attachments

Pharma Q3 Fin Result.pdf
327.9 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2016

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Sep 2016
30 Sep 2015
30 Sep 2016
30 Sep 2015
$$'000
$$'000
$$'000
$$'000
1 Revenue
515,215
524,413
1,606,206
1,509,162
2 Profit/(loss) before tax
19,923
25,337
67,948
89,005
3 Profit/(loss) for the period
12,648
19,975
46,759
68,543
4 Profit/(loss) attributable to ordinary equity holders of the parent
13,061
19,971
46,435
67,982
5 Basic earnings/(loss) per share (Subunit)
5.04
7.71
17.93
26.26
6 Proposed/Declared dividend per share (Subunit)
4.00
9.00
13.00
23.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
2.0500
2.0400

Remarks :
Net assets per share had been adjusted retrospectively to reflect the Company's new shares issued under Long Term Incentive Plan on 11 and 12 July 2016 and Share Option Plan on 26 July 2016.

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 21 Nov 2016
Category Financial Results
Reference Number FRA-18112016-00031